NEW YORK (GenomeWeb News) – Abbott will be the sole distributor of Luminex Molecular Diagnostics’ respiratory viral panel outside of the United States, Luminex said today.
 
Under the agreement, Abbott will have exclusive rights to distribute the xTAG RVP outside of the US and semi-exclusive rights within the US, Luminex said.
 
The xTAG received 510(k) clearance from the US Food and Drug Administration in January 2008, and it was CE marked for sale in Europe in November 2006.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.